Germany asks firms selling blood thinner heparin to examine stocks for contamination - International Herald Tribune

Germany asks firms selling blood thinner heparin to examine stocks for contamination - International Herald Tribune: "Companies in Germany that sell heparin, a drug used to thin blood, have been ordered to test their stocks for any signs of contamination, a week after a company recalled several batches because 80 dialysis patients fell sick.

Ulrich Hagemann, who oversees pharmaceutical safety for the Federal Institute for Drugs and Medical Devices, or BFARM, said the directive was issued as 'a precautionary measure.' He added no new cases of adverse reactions had been found among patients using heparin." [IHT.com]